Accenture plc (ACN) Stock Analysis

65.0/100
Buy Not Halal Technology
Price $250.49
Market Cap $148.05B
52-Week Change +1.18%

Is ACN a good investment?

Accenture plc (ACN) has a Plutrex AI rating of 65.0/100 as of November 04, 2026, indicating a Buy consensus. The stock is not classified as halal-compliant. Key strength: Operating margin 17.83% is +40.4% above industry average 12.70%, combined with net margin 11.28% (+58.2% above industry 7.13%) and ROE 26.7% (+60.7% above industry 16.59%) — ACN is unambiguously the most profitable operator in its peer group with durable competitive advantages. Main concern: PEG ratio has worsened from 2.36 to 2.51 in 14 days (PE expanded from 17.63x to 18.73x while growth unchanged) — stock now trades $19.25 ABOVE analyst consensus of $235.31, meaning the market has priced in all good news and then some; negative potential return of -7.6% to consensus.

Investment Summary

Accenture (ACN) at $254.56 is a genuinely exceptional business — operating margin 17.83% (vs industry 12.70%), ROE 26.7% (vs industry 16.59%), FCF $11.6B, D/E 0.40x (vs industry 0.95x) — but it has become increasingly expensive. The P/E has expanded from 17.63x to 18.73x in 14 days while EPS growth expectations are unchanged at 7.5-8.7%, pushing the PEG from 2.36 to 2.51. The stock now trades $19.25 ABOVE analyst consensus of $235.31, meaning even Wall Street's bulls see -7.6% downside from here. The CEO buying $3M of stock post-dip is a mild positive signal, but it doesn't change the valuation math: paying 2.51x per unit of growth for a company growing earnings at 7.5-8.7% annually requires either multiple expansion (unlikely given current premium) or a long wait for earnings to grow into the price. The business is excellent; the entry point is not.

Key Strengths

Key Concerns

Plutrex 10-Factor AI Breakdown

Financial Health
97/100
Growth Potential
38/100
Valuation
30/100
Profitability
87/100
Debt Management
98/100
Analyst Sentiment
70/100
Technical Momentum
55/100
Insider Confidence
65/100
News Sentiment
85/100

Fundamental Analysis

ACN scores 82/100 on profitability and 80/100 on health but only 38/100 on valuation and 45/100 on growth. Profitability is industry-leading: gross margin 31.7% (vs industry 30.73%), operating margin 17.83% (+40.4% above industry avg 12.70%), net margin 11.28% (+58.2% above industry avg 7.13%), ROE 26.7% (+60.7% above industry avg 16.59%). Balance sheet is a fortress: D/E 0.40x (vs industry 0.945x), $12.84B cash, $11.62B annual FCF. The critical flaw is valuation: PE 18.73x against 7.5% 5-year EPS growth yields PEG 2.51 — well above the 2.0x caution threshold. Forward 5-year EPS growth of 7.47% actually lags the industry average of 7.93% by -5.8%, meaning ACN pays a PE premium (+12.2% vs peers) while delivering below-average medium-term growth. Revenue growth of 6.2% lags the industry average of 9.14% by -32.2%. Analyst consensus target $235.31 implies -7.6% downside — the buy case requires 7-8 months of earnings growth just to get back to analyst fair value at current price.

News Sentiment

Accenture is dominating investor watchlists right now — but the question is whether the consulting giant's stock has gotten too expensive for its own good. The company has earned a rare trifecta of recognition, appearing in Zacks portfolios simultaneously as a 'Top Growth Stock for the Long-Term,' a 'Top Value Stock for the Long-Term,' and a competitive alternative to Microsoft for 2027 — a remarkable feat that underscores ACN's crossover appeal to multiple investor styles. Perhaps most notably, Accenture's own CEO made a $3 million personal stock purchase after shares doubled off their June lows, sending a powerful signal of insider confidence in the company's trajectory. The comparison to Microsoft in a head-to-head 2027 outlook analysis positions Accenture as a serious contender in the AI transformation race, while a separate piece examining 'Accenture vs. Innodata' on AI growth potential highlights the company's reputation as a leading force in enterprise AI deployment. Yet beneath the positive headlines lurks a complicating factor: Accenture capped employees' access to AI tools like Claude at just $29 per month — a detail that raised eyebrows given the company's premium positioning as an AI transformation advisor to Fortune 500 clients. For now, investor sentiment is running hot (89.3/100), but the stock's current price of $254.56 — already $19 above what analysts think it's worth — suggests the good news may already be priced in.

Risk Assessment

PRIMARY RISK: Valuation compression. ACN at $254.56 trades at PEG 2.51 and $19.25 above analyst consensus. Any slowdown in IT consulting demand, pricing pressure from AI automation of services, or multiple compression toward the peer average (PE 16.70x) would imply $224-$228 fair value — a 10-12% drawdown from current levels without any fundamental deterioration. SECONDARY RISK: AI displacement paradox — Accenture consults clients on AI transformation while capping internal AI tool usage at $29/month, creating reputational inconsistency that could chip at the premium narrative. TERTIARY RISK: Revenue growth lagging peers at 6.2% vs 9.14% industry average suggests structural growth deceleration at scale. MITIGATION: The fortress balance sheet ($12.84B cash, $11.62B FCF, D/E 0.40x) and industry-leading margins provide a durable floor — this is not a business at risk of implosion. The stop at $205 is below DCF fair value floor of $210-$215, representing a thesis break. At $223 entry (midpoint), risk is $18 to stop ($205), and upside to $240-$250 (12-month price target assuming 7.5% EPS growth + modest re-rating) is approximately $17-$27, yielding 1.0-1.5x risk/reward — acceptable only at a small position size.

Related Halal Stocks

Related Stocks

Frequently Asked Questions

Is ACN a halal stock?

No, Accenture plc (ACN) is currently not classified as halal by AAOIFI criteria.

What is Plutrex's AI rating for ACN?

Accenture plc (ACN) has a Plutrex AI rating of 65.0/100 with a Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.

Is ACN a good investment?

According to Plutrex AI, ACN has a Buy rating (65.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.

How can I invest in ACN?

US stocks like ACN can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. ElBarake provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.

What are the main risks of investing in ACN?

Plutrex AI identifies the main risks for ACN by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.

Chat with ElBarake AI about ACN

Ask anything about this stock and get an instant AI-powered answer — free, no signup required.

Open ACN in ElBarake